Literature DB >> 19706911

Comparison of prednisolone plus albendazole with prednisolone alone for treatment of patients with eosinophilic meningitis.

Verajit Chotmongkol1, Suvicha Kittimongkolma, Kanigar Niwattayakul, Pewpan M Intapan, Yupa Thavornpitak.   

Abstract

Corticosteroid and the combination of corticosteroid and antihelminthic drug are safe and beneficial in relieving headaches in patients with eosinophilic meningitis. However, clinical trials comparing the efficacies of these regimens have never been reported. We conducted a prospective, open, randomized, controlled study to compare the efficacy of the combination of prednisolone plus albendazole and prednisolone alone for the treatment of eosinophilic meningitis. Our study had 53 patients in the combined treatment group and 51 patients in the prednisolone alone group. There were no significant differences between the two groups with regard to the number of patients who still had headaches after 14 days (0 versus 1, respectively; P = 0.49) and the median length of time until complete disappearance of headache (3 versus 3 days, respectively; P = 0.32. Prednisolone plus albendazole is no better than prednisolone alone for treatment of patients with eosinophilic meningitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706911

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  27 in total

1.  Treatment of angiostrongyliasis using a combination of albendazole and dexamethasone: the results of a retrospective and comparative study.

Authors:  Z Diao; J Wang; H Qi; X Li; X Zheng; C Yin
Journal:  Ann Trop Med Parasitol       Date:  2011-01

2.  Guess who's coming to dinner? Emerging foodborne zoonoses.

Authors:  David N Fisman; Kevin Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

3.  First Evidence of Angiostrongyliasis Caused by Angiostrongylus cantonensis in Guadeloupe, Lesser Antilles.

Authors:  Céline Dard; Jean-Eudes Piloquet; Yvonne Qvarnstrom; LeAnne M Fox; Helmi M'kada; Jean-Christophe Hebert; Didier Mattera; Dorothée Harrois
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

Review 4.  Central nervous system manifestations of Angiostrongylus cantonensis infection.

Authors:  Yuri C Martins; Herbert B Tanowitz; Kevin R Kazacos
Journal:  Acta Trop       Date:  2014-10-13       Impact factor: 3.112

Review 5.  Corticosteroids for parasitic eosinophilic meningitis.

Authors:  Sikawat Thanaviratananich; Sanguansak Thanaviratananich; Chetta Ngamjarus
Journal:  Cochrane Database Syst Rev       Date:  2015-02-17

6.  Anti-inflammatory effect of prednisolone on the growth of human liver fluke in experimental opisthorchiasis.

Authors:  Amornrat Juasook; Thidarut Boonmars; Sasithorn Kaewkes; Watcharin Loilome; Kulathida Veteewuthacharn; Zhiliang Wu; Puangrat Yongvanit
Journal:  Parasitol Res       Date:  2011-12-21       Impact factor: 2.289

Review 7.  [Parasitic diseases of the central nervous system].

Authors:  E Schmutzhard
Journal:  Nervenarzt       Date:  2010-02       Impact factor: 1.214

Review 8.  Clinical aspects of eosinophilic meningitis and meningoencephalitis caused by Angiostrongylus cantonensis, the rat lungworm.

Authors:  Gerald S Murphy; Stuart Johnson
Journal:  Hawaii J Med Public Health       Date:  2013-06

9.  A severe case of Angiostrongylus eosinophilic meningitis with encephalitis and neurologic sequelae in Hawa'i.

Authors:  Edward Kwon; Tomas M Ferguson; Sarah Y Park; Augustina Manuzak; Yvonne Qvarnstrom; Stephen Morgan; Paul Ciminera; Gerald S Murphy
Journal:  Hawaii J Med Public Health       Date:  2013-06

10.  Identification of factors associated with clinically severe angiostrongyliasis.

Authors:  Zongli Diao; Hongli Xiao; Jing Wang; Haiyu Qi; Xiaoli Li; Chenghong Yin
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.